$481 Million is the total value of Essex Woodlands Management, Inc.'s 8 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PSDV | Buy | EYEPOINT | $149,597,000 | +182.4% | 41,903,956 | +64.5% | 31.11% | +152.9% |
| AXGN | AXOGEN INC | $136,754,000 | -26.7% | 3,711,111 | 0.0% | 28.44% | -34.3% | |
| CORI | CORIUM | $88,950,000 | +18.7% | 9,353,304 | 0.0% | 18.50% | +6.3% | |
| RVNC | REVANCE THERAPEUTICS INC | $83,050,000 | -9.5% | 3,342,047 | 0.0% | 17.27% | -18.9% | |
| MNOV | MEDICINOVA INC | $14,618,000 | +56.9% | 1,170,370 | 0.0% | 3.04% | +40.5% | |
| ELGX | ENDOLOGIX INC | $6,684,000 | -50.9% | 1,257,468 | 0.0% | 1.39% | -56.1% | |
| CBIO | CATALYST | $861,000 | -7.7% | 78,622 | 0.0% | 0.18% | -17.5% | |
| ACUR | ACURA PHARMACEUTICALS INC | $372,000 | -47.2% | 1,956,397 | 0.0% | 0.08% | -52.8% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MEDICINOVA INC | 42 | Q3 2023 | 6.5% |
| REVANCE THERAPEUTICS INC | 39 | Q3 2023 | 44.6% |
| AXOGEN INC | 26 | Q4 2021 | 43.3% |
| ENDOLOGIX INC | 24 | Q1 2019 | 22.5% |
| ABIOMED INC | 20 | Q1 2018 | 52.1% |
| CORIUM INTL INC | 20 | Q1 2019 | 23.5% |
| TELA BIO, INC. | 16 | Q3 2023 | 31.5% |
| VENUS CONCEPT, INC. | 16 | Q3 2023 | 21.3% |
| ACURA PHARMACEUTICALS INC | 15 | Q1 2019 | 1.4% |
| CATALYST BIOSCIENCES INC | 15 | Q1 2019 | 1.0% |
View Essex Woodlands Management, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Essex Woodlands Management, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.